Literature DB >> 19815313

[INCA study: cardiac failure or vascular risk?].

Manuel Méndez Bailón, Nuria Muñoz Rivas.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19815313      PMCID： PMC7022074          DOI： 10.1016/j.aprim.2009.07.009

Source DB:  PubMed          Journal:  Aten Primaria        ISSN： 0212-6567            Impact factor:   1.137


× No keyword cloud information.
  5 in total

1.  [Brain natriuretic peptide in primary care: diagnostic value in heart failure].

Authors:  A I González-González; J M Lobos-Bejarano; C Horrillo-García; J Castellanos-Maroto; S Díaz-Sánchez; A Castellanos-Rodríguez; J L Martínez-Carrasco; M Taboada-Tabeada; J L Miraflores-Carpio
Journal:  Aten Primaria       Date:  2005-11-30       Impact factor: 1.137

2.  Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMES.

Authors:  Hans Persson; Eva Lonn; Magnus Edner; Lawrence Baruch; Chim C Lang; John J Morton; Jan Ostergren; Robert S McKelvie
Journal:  J Am Coll Cardiol       Date:  2007-01-26       Impact factor: 24.094

3.  Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients.

Authors:  Alejandro de la Sierra; Josep Redon; José R Banegas; Julián Segura; Gianfranco Parati; Manuel Gorostidi; Juan J de la Cruz; Javier Sobrino; José L Llisterri; Javier Alonso; Ernest Vinyoles; Vicente Pallarés; Antonio Sarría; Pedro Aranda; Luis M Ruilope
Journal:  Hypertension       Date:  2009-01-26       Impact factor: 10.190

4.  [Clinical profile and management patterns in outpatients with heart failure in Spain: INCA study].

Authors:  Beatriz de Rivas Otero; Gaieta Permanyer-Miralda; Carlos Brotons Cuixart; Joaquin Aznar Costa; Eduardo Sobreviela Blázquez
Journal:  Aten Primaria       Date:  2009-05-09       Impact factor: 1.137

5.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Authors:  Peter Sleight; Josep Redon; Paolo Verdecchia; Giuseppe Mancia; Peggy Gao; Robert Fagard; Helmut Schumacher; Michael Weber; Michael Böhm; Bryan Williams; Janice Pogue; Teo Koon; Salim Yusuf
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.